ULURU Announces Approval to Market Altrazeal in Australia

by Eddie Staley, Benzinga Editor
February 23, 2012 8:03 AM | 10 seconds read | Make a Comment
Loading...
Loading...
ULURU Inc.
ULU
,announced today that an Australian Register of Therapeutic Goods Certificate has been issued by the Therapeutic Goods Administration approving the marketing of Altrazeal® in Australia.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Posted In: NewsFDAGlobal
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!